Lupus & Connective Tissue Diseases
Conference Coverage
Real-world data reinforce stem cell transplant for progressive systemic sclerosis
In real-world study, stem cell transplant provides major advantages for rapidly progressive systemic sclerosis if strict selection criteria are...
Feature
PAH care turns corner with new therapies, intensified monitoring
Conference Coverage
Absolute increase in Kawasaki CV risk remains small in long-term follow-up
Relative to controls, the increased long-term cardiovascular risk of patients with Kawasaki disease is small in most patients.
Latest News
Lilly calls it quits on baricitinib’s development for lupus
The company said it is stopping phase 3 trials because of disappointing results.
Feature
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
From the Journals
One-third of trials for connective tissue diseases go unpublished
Smaller studies were more likely than larger studies to be discontinued or unpublished.
From the Journals
Low BMI, weight loss predict mortality risk in ILD
News
FDA approves new myasthenia gravis drug
This approval represents “an important step in providing a novel therapy option” for patients with the rare disease.
Opinion
A 22-year-old presented with erythematous papules on her fingers and toes
A 22-year-old with a history of ITP presented with 2 months of asymptomatic erythematous papules on her fingers and toes.
Feature
Giant cell arteritis fast-track clinics pave way for greater ultrasound use in U.S.
Fast-track clinics are using vascular ultrasound to streamline diagnosis of giant cell arteritis, but the United States has a way to go to catch...
Conference Coverage
Validity of commercial serologic tests for dermatomyositis still questionable
“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”